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Abstract
Background: Vesicoureteral reflux (VUR) is frequently found after transplantation, but its impact on graft function, urine tract
infection, and graft loss remains uncertain. Therefore our objective was to evaluate the effects of VUR on the outcome of renal
transplantation. Material and Methods: We included 1008 adult renal transplant recipients of whom a 1-week posttransplant
voiding cystourethrogram was available. Study end points included occurrence of bacteriuria, renal function, and graft survival.
Results: In total, 106 (10.5%) of 1008 graft recipients had a diagnosis of VUR on voiding cystography. The incidence of bacteriuria
was comparable in the reflux and nonreflux group (17% vs 17.4%, P¼ .91). There was no significant difference in renal function at
3 months and 1 year in patients with and without VUR. One- and 5-year graft survival in patients with VUR was 85.8% and 82.1%
compared to 87.3% and 83.0% in patients without VUR (P ¼ .68 and P ¼ .80). Conclusion: Posttransplant VUR has no
correlations with early bacteriuria, renal function, and graft survival.
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Background
Urological complications are the most frequent technical adverse
event after renal transplantation andcanhavea significant effect on
long-term allograft survival and loss. Vesicoureteral reflux (VUR)
into the transplanted kidney occurs frequently after transplanta-
tion.1 However, the effect of VUR on both early and late graft
function and graft survival remains doubtful. Early findings indi-
cated VUR as an important cause of late renal-graft failure.2 More
recent studies did not convincingly support this evidence.3-9 Urine
tract infection (UTI) is a common finding after kidney transplanta-
tion, with incidences ranging from 6% to 86%, thereby making it
the most frequent infection in renal transplant recipients.10,11 The
aim of this study was to investigate the impact of VUR on short-
term and long-term clinical graft outcomes and early postsurgical
bacteriuria frequency in our renal transplant series.
Material and Methods
Design
A retrospective cohort study was performed. This retrospec-
tive chart review was exempted from the institution’s ethical
board review.
Setting
The study took place at the Academic Medical Center
of Amsterdam.
Population
In this retrospective study, we included 1008 of 1358 adult
patients who underwent kidney transplantation at the Aca-
demic Medical Center of Amsterdam, between January 1995
and April 2012. For study inclusion, a posttransplant voiding
cystourethrogram (VCUG) had to be available. Absence of a
VCUG was the only exclusion criteria for this study.
Data Collection
Patient charts and surgical reports were reviewed retrospec-
tively. Patient baseline characteristics are represented in Table 1.
For this study, documented end points included occurrence of
bacteriuria during the initial hospital stay (asymptomatic or UTI),
renal function (serum creatinine levels after 3 months and 1 year),
and graft survival. Graft survival was defined as being alive with a
functioning graft (free from dialysis or repeat renal
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transplantation). Diagnosis of bacteriuria included both asympto-
matic bacteriuria andUTI. The diagnosis ofUTIwas based onboth
clinical symptoms (dysuria, urgency, frequency, fever, and tender-
ness of renal allograft) suggestive forUTI alongwith bacteriuria. In
case of clinical diagnosis of UTI, bacteriuria was defined as a
positive midstream urine specimen culture showing growth of an
uropathogen with at least 104 colony-forming units per milliliter
(CFU/mL). Asymptomatic bacteriuria was defined as a bacteriuria
(at least 105 CFU/mL) without any clinical symptoms suggestive
for UTI. Specimens were taken after catheter removal and during
the initial hospital stay. Surveillance for bacteriuria occurred
through screening for leukocyturia within the urine sediment. In
case of leukocyturia, a urine culture was taken. A urine culturewas
also taken in case of fever or urinary tract symptoms.
Data Analysis
Continuous data were given as the mean, the 95% confidence
interval, and the standard deviation. For comparison between
these continuous data, which had a normal distribution, the
independent samples t test was used. Discrete data were dis-
played as counts and percentages and for comparison of cate-
gorical data we used z tests. Kaplan–Meier analysis was used to
calculate graft and patient survival. A 2-sided P value of <.05
was considered statistically significant. Statistical analysis was
performed using IBM SPSS statistic for Mac OS, version 21.0
(IBM Corp, Armonk, New York).
Procedure
All transplantations were performed through an extraperitoneal
approach in the iliac fossa. All recipients received 1 gm of
cefamandole intravenously as antibiotic prophylactic 30 minutes
prior to incision. In 2011, cefamandole was switched to 1 gm
cefazolin. The method used to establish urinary continuity was
either the extravesical ureteroneocystostomy (Lich–Gregoir
method) or the intravesical ureteroneocystostomy (Politano–
Leadbetter method), according to personal preference of the
surgeon . Until July 2005, all ureter–bladder anastomoses were
performed without stenting. From July 2005 onward, all renal
transplant recipients received a 5-day 8F external stented ureter-
oneocystostomy. The stent was introduced into the bladder
through a direct suprapubic bladder puncture and positioned in
the transplant renal pelvis. From 2007, the stent protocol chan-
ged. Living renal transplants had continuous use of the external
8F splint, but the deceased donor renal transplants received a 12-
cm long 6F ureteral double-J stent for 6 weeks. Postoperatively,
all patients had an indwelling bladder catheter, which was
removed in all patients on day 7 after urinary leakage had been
excluded by VCUG. Voiding cystourethrogramwas reviewed by
a radiologist and scored on the presence of VUR in the trans-
planted kidney. When contrast fluid was present in the trans-
planted ureter or pyelum, VUR was diagnosed. No grading was
used. All patients were followed at our center for at least 1 year
after successful transplantation. After 1 year, most patients were
transferred to their referral center.
Results
In total, 106 (10.5%) of 1008 graft recipients had a diagnosis of
VUR on VUCG. Table 1 presents the baseline characteristics
and the results. No significant difference was observed in renal
function at 3 months and 1 year between both groups.
Table 1. Baseline Characteristics and Results.
Variables Reflux (n ¼ 106) No Reflux (n ¼ 902) Odds Ratio (95% CI) P Value
Baseline characteristics
Recipient age, years, mean (SD) 44.6 (15.7) 44.8 (16.8) .93
Prior kidney transplantation, n (%) 26 (25) 149 (17) 1.640 (16.5 to 0.6) .07
Determinants of graft outcome
Live donor transplantation, n (%) 19 (18) 247 (27) 0.584 (17.4 to 1.4) .02
Deceased donor transplantation, n (%) 85 (82) 645 (73) 1.713 (1.4 to 17.4) .02
Cold ischemia time, minutes, mean (SD), deceased donors 1432 (568) 1403 (473) .61
Posttransplant bacteriuria
Positive urine culture, n (%) 18 (17) 157 (17.4) 0.97 (5.24 to 4.68) .91
Bladder anastomosis
Extravesical (LG), n (%) 89 (89) 674 (75) 2.42 (5.3 to 18.8) <.01
Intravesical (PL), n (%) 11 (11) 202 (25) 0.41 (18.8 to 5.3) <.01
Posttransplant renal function (serum creatinine levels in mmol/L)
3 months, mean (SD) 199 (187) 198 (201) .99
1 year, mean (SD) 160 (81) 152 (81) .53
Stenting
No stent, n (%) 73 (70) 659 (73) .36
External stent, n (%) 8 (8) 92 (10) .67
JJ stent, n (%) 24 (23) 143 (16) .21
Graft survival
1-year graft survival, n (%) 91 (85.8) 787 (87.3) 0.89 (0.50 to 1.58) .68
5-year graft survival, n (%) 87 (82.1) 749 (83.0) 0.94 (0.55 to 1.58) .80
Abbreviations: CI, confidence interval; JJ, Double-J stent; LG, Lich-Gregoir method; PL, Politano-Leadbetter method; SD, standard deviation.
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The incidence of bacteriuria was 17.4%. Incidence rates did
not differ significantly between patients with or without reflux;
17.0% of the patients with VUR were diagnosed with a bacter-
iuria and 17.4% of the nonreflux group (P ¼ .91).
Rates of VUR did differ with the implementation technique,
with a higher incidence of VUR with the Lich–Gregoir method
compared to the Politano–Leadbetter method (12.0% vs 5.0%;
P < .001). The UTI rate was 24.9% with the Lich–Gregoir
method compared to 15.2% with the Politano–Leadbetter
method (P < .01).
Rates of VUR did not significantly differ with different
stenting protocols. The incidence of VUR in the nonstent group
was 10.0%, compared to 8.0% in the external stent group and
14.0% in the double-J stent group (P ¼ .178).
Bacteriuria rate did show a difference between stenting pro-
tocols with an incidence of 23.0% in the nonstent group com-
pared to 3.0% and 1.7% in the external stent and the Double-J
stent group (P < .05), respectively.
There was no significant difference in graft survival at 1 and
5 years between both groups, as can been seen in the Kaplan–
Meijer survival curve in Figure 1.
Discussion
In our retrospective study of 1008 kidney transplant patients,
we found a VUR rate of 10.5%. The overall incidence of bac-
teriuria was 17.4%, which did not differ significantly between
patients with or without VUR. No effect of VUR has been
observed on renal function and graft survival.
Previously published data reported a highly variable inci-
dence of VUR, with incidences of VUR up to 86%.4,7 Voiding
cystourethrogram in these studies, however, was sometimes
performed in selected patient cohorts, instead of our standar-
dized per-protocol VCUG. Margreiter et al reported an inci-
dence of VUR of 40.7%, which is considerably higher than our
10.5%. Our cohort showed a significantly lower incidence of
VUR using intravesical ureteroneocystostomy compared to the
extravesical method, which has not been used in patients of the
cohort of Margreiter et al. In accordance with the findings of
Margreiter et al, we found that the incidence of VUR was
higher among patients receiving a deceased donor kidney com-
pared to live donor transplants.
Bacteriuria, especially when it is recurrent, influences renal
allograft outcome unfavourably.10,12 The overall prevalence of
bacteriuria was 17.4% in our patient group. Other studies have
reported an incidence ranging from 6% to 86%.10 The VUR has
been discussed as being of a possible influence on the occur-
rence of bacteriuria, but findings have been inconclusive. Most
studies did not find a relation between VUR and occurrence of
bacteriuria,4,5,7 which is in accordance with our findings.
Main objective of this study was to contribute to the debate
whether VUR is of influence on graft function and survival. To
evaluate graft function, we used creatinine levels at 3 months
and 1 year. Several other studies report on graft function using
either creatinine levels or estimated glomerular filtration rate
(GFR). Coosemans et al3 measured creatinine levels at several
time points and only found a significant difference at day 1 and
day 7, after which this difference disappeared. However, Coo-
semans et al only had a VUR population of 3.82% (n ¼ 15).
Two other studies could not find a difference as well.4,5 Inoue
et al found the existence of VUR was independently associated
with a 24-hour creatinine clearance of less than 60 mL/min
(odds ratio ¼ 2.993; P ¼ .033).6 Margreiter et al could only
find significantly lower estimated GFR (eGFR) levels at 1-year
posttransplantation; the difference disappeared at 3 and 5 years
posttransplantation.7 Our results are in accordance with the
current literature, which during a follow-up period of 2 to 5
years did not demonstrate significant graft survival rates in
patients with or without VUR.3,5,7
Although our population has reached a large number, our
study still has its limitations. Primarily, it is a retrospective
study, and of the 1358 patients who received a kidney trans-
plant, only 1008 could be included since VCUG was lacking in
350 patients. Also, there were no follow-up VCUGs available.
Unknown is whether reflux could disappear naturally after a
few weeks when the surgical site is completely healed or
whether reflux actually can arise later on. Earlier findings show
that VUR may change with time after surgery.13
Observation of bacteriuria only took place during initial
admission to the hospital. Bacteriuria diagnosed at some other
point during follow-up was not registered.
We used serum creatinine to objectify graft function. Unfor-
tunately, we did not have enough data to calculate eGFR. Lack
of data on bodyweight among others makes the use of serum
creatinine as graft function less reliable.
Conclusion
Our study reported on the largest number of patients so far
concerning VUR. In our data, no indications were found
demonstrating that VUR has a negative influence on graft func-
tion, or graft survival rates of bacteriuria, renal function, and
Figure 1. One- and 5-year graft survival rates for patients with and
without vesicoureteral reflux.
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graft survival did not differ between patients with or without
posttransplant VUR.
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